{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T15:24:14Z","timestamp":1761578654311,"version":"build-2065373602"},"reference-count":12,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007120","name":"Society of Thoracic Surgeons","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007120","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005485","name":"American College of Cardiology Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005485","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.carrev.2020.04.003","type":"journal-article","created":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T10:32:08Z","timestamp":1585996328000},"page":"707-711","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Review of CRT 2020 Late-breaking Trials"],"prefix":"10.1016","volume":"21","author":[{"given":"Charan","family":"Yerasi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian C.","family":"Case","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian J.","family":"Forrestal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron","family":"Waksman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.carrev.2020.04.003_bb0005","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.jacc.2019.12.057","article-title":"TAVR in low-risk patients: FDA approval, the new NCD, and shared decision-making","volume":"75","author":"Coylewright","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2020.04.003_bb0010","article-title":"Transcatheter aortic valve replacement in low-risk patients with symptomatic severe bicuspid aortic valve stenosis","volume":"4961","author":"Waksman","year":"2020","journal-title":"J Am Coll Cardiol Intv"},{"issue":"18","key":"10.1016\/j.carrev.2020.04.003_bb0015","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/j.jacc.2018.08.1033","article-title":"Transcatheter aortic valve replacement in low-risk patients with symptomatic severe aortic stenosis","volume":"72","author":"Waksman","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.carrev.2020.04.003_bb0020","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1056\/NEJMoa1911426","article-title":"Reduced leaflet motion after transcatheter aortic-valve replacement","volume":"382","author":"De Backer","year":"2020","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.carrev.2020.04.003_bb0025","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.119.009608","article-title":"Hemodynamics and subclinical leaflet thrombosis in low-risk patients undergoing transcatheter aortic valve replacement","volume":"12","author":"Khan","year":"2019","journal-title":"Circ Cardiovasc Imaging"},{"author":"Makkar","key":"10.1016\/j.carrev.2020.04.003_bb0030"},{"issue":"7","key":"10.1016\/j.carrev.2020.04.003_bb0035","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.119.007258","article-title":"Pivotal clinical study to evaluate the safety and effectiveness of the MANTA percutaneous vascular closure device","volume":"12","author":"Wood","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2020.04.003_bb0040","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.carrev.2020.02.012","article-title":"Long-term survival following transcatheter mitral valve repair: pooled analysis of prospective trials with the Carillon device","volume":"21","author":"Lipiecki","year":"2020","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.carrev.2020.04.003_bb0045","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1056\/NEJMoa1910021","article-title":"Polymer-based or polymer-free stents in patients at high bleeding risk","volume":"382","author":"Windecker","year":"2020","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.carrev.2020.04.003_bb0050","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1161\/CIRCULATIONAHA.117.029289","article-title":"Standardized end point definitions for coronary intervention trials: the Academic Research Consortium-2 consensus document","volume":"137","author":"Garcia-Garcia","year":"2018","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.carrev.2020.04.003_bb0055","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1016\/j.jacc.2018.09.019","article-title":"Ultrathin bioresorbable polymer sirolimus-eluting stents versus thin durable polymer everolimus-eluting stents","volume":"72","author":"Kandzari","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2020.04.003_bb0060","article-title":"Ultrathin bioresorbable polymer sirolimus-eluting stents versus thin durable polymer everolimus-eluting stents for coronary revascularization: three-year outcomes from the randomized BIOFLOW V trial","volume":"4973","author":"Kandzari","year":"2020","journal-title":"J Am Coll Cardiol Intv"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838920301779?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838920301779?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:17:28Z","timestamp":1761560248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838920301779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S1553838920301779"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2020.04.003","relation":{},"ISSN":["1553-8389"],"issn-type":[{"type":"print","value":"1553-8389"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Review of CRT 2020 Late-breaking Trials","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2020.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}